We are a London-based biopharmaceutical company using our expertise of opioid antagonists to develop modern addiction treatments. Right now, our focus is on completing the clinical trials of an opioid antagonist-based nasal spray for the treatment of Binge Eating Disorder, which is the……
  Learn more about our products in development.
Binge Eating Disorder Treatment
Bulimia Nervosa Treatment
Prospective Treatments

LLTP Signs Agreement with Manufacturer for Opioid Overdose Reversal Treatment
Phillip Seymour Hoffman Didn't have to Die ("Time")
Joint Clinical Trial with NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose a Promising Treatment
LLTP to Present at 6th Annual LD Micro Conference
LLTP Commences Two  Week Patient Trial with NIDA for Treatment of Opioid Overdose
Attention Opioid Addicts: Studies Could Save You from Fatal Overdose ("Forbes")

LLTP Announces Partnership with NIDA to Treat Opioid Overdose

LLTP Partners with NIDA to Expand Access to Opioid Overdose Medication ("NIDA")
LLTP Retains KCSA as Corporate Communications Advisors

Video of Dr. Crystal at OneMedForumNY

LLTP to Present at OneMedForumNY

LLTP to Develop Opioid Drug Treatment in Collaboration with the National Institute on Drug Abuse (NIDA)

(archived releases)